Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lin Kai Fang"'
Autor:
Bi Yao Mo, Xing Hua Guo, Meng Ru Yang, Fang Liu, Xuan Bi, Yan Liu, Lin Kai Fang, Xi Qing Luo, Julie Wang, Joseph A. Bellanti, Yun Feng Pan, Song Guo Zheng
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Rapidly accumulating evidence has now suggested that the long non-coding RNAs (LncRNAs), a large and diverse class of non-coding transcribed RNA molecules with diverse functional roles and mechanisms, play a major role in the pathogenesis of many hum
Externí odkaz:
https://doaj.org/article/77c78f90c4bb4e2cb6fe3fdebf3c9059
Autor:
X. Guo, Lin Kai Fang, Yan Liu, Xi Qing Luo, Xuan Bi, Joseph A. Bellanti, Song Guo Zheng, Meng Ru Yang, Fang Liu, Bi Yao Mo, Julie Wang, Y. Pan
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Rapidly accumulating evidence has now suggested that the long non-coding RNAs (LncRNAs), a large and diverse class of non-coding transcribed RNA molecules with diverse functional roles and mechanisms, play a major role in the pathogenesis of many hum
Autor:
Yunfeng Pan, Fang Liu, Yun Ting Wu, Song Guo Zheng, Bi Yao Mo, Yan Liu, Nancy J. Olsen, Meng Ru Yang, Lin Kai Fang, You Qiu Xue, Meng Liu, X. Guo, Xin Guo
Urokinase-type plasminogen activator receptor (uPAR), is a multifunctional receptor on cell surface, widely present in endothelial cells, fibroblasts, and a variety of malignant cells. Current studies have suggested that uPAR overexpressed on synovia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::483c415bb40f9e20e085ec5c213779b5
https://europepmc.org/articles/PMC5811678/
https://europepmc.org/articles/PMC5811678/
Anti-TNF therapy in patients with HBV infection--analysis of 87 patients with inflammatory arthritis
Autor:
Jinwei Chen, Xue-feng Pang, Lijun Wu, Yi-jia Chen, Lin-kai Fang, Rong Mu, Zhanguo Li, Hua Ye, Jin Lin, Jieruo Gu, Xuewu Zhang, Jin-feng Du
Publikováno v:
Clinical rheumatology. 33(1)
This study aims to investigate the incidence of hepatitis B virus (HBV) reactivation in inflammatory arthritis (IA) patients with HBV infection using anti-tumor necrosis factor (TNF) agents and evaluate the efficacy of antiviral therapy in reducing t